PRQR

ProQR Therapeutics N.V.

Price

$1.86

return (12m)

-11.67%

p/e

-4.81

p/bv

2.57

DIVIDEND YIELD

0.00%

PRQR price

ProQR Therapeutics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PRQR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

-20.90%

3 months

-1.85%

1 year

-11.67%

2 years

4.21%

5 years

-75.85%

10 years

-74.09%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals PRQR

Valuation

P/E

-4.81

Sector -3.50

Industry -3.50

P/BV

2.57

Sector 2.02

Industry 2.02

P/Revenue (PSR)

11.03

Sector 2.01

Industry 2.01

EV/EBITDA

-10.70

Sector -214.99

Industry -214.99

EV/EBIT

-9.84

Sector -47.59

Industry -47.59

P/EBITDA

-5.33

Sector -21.41

Industry -21.41

P/EBIT

-4.97

Sector -28.65

Industry -28.65

P/Total Assets

1.53

Sector 1.19

Industry 1.19

P/Net Current Assets

3.02

Sector -11.97

Industry -11.97

P/Working Capital

2.35

Sector -167.95

Industry -167.95

EPS

-0.39

Sector -1.81

Industry -1.81

BVPS

0.72

Sector 2.06

Industry 2.06

Efficiency

Gross Margin

100.00%

Sector 41.30%

Industry 41.30%

EBITDA Margin

-92.65%

Sector -17,117.21%

Industry -17,117.21%

EBIT Margin

-100.72%

Sector -4,185,659.35%

Industry -4,185,659.35%

Operating Margin

-100.00%

Sector -35.21%

Industry -35.21%

Net Profit Margins

-100.00%

Sector -35.91%

Industry -35.91%

Asset Turnover

0.07

Sector 0.02

Industry 0.02

Profitability

ROE

-53.39%

Sector -56.04%

Industry -56.04%

ROA

-31.78%

Sector -60.31%

Industry -60.31%

ROIC

-75.35%

Sector -2,335.95%

Industry -2,335.95%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.49

Sector 2.89

Industry 2.89

Net Debt / EBITDA

14.43

Sector -14,066,680.10

Industry -14,066,680.10

Net Debt / EBIT

13.28

Sector -8.06

Industry -8.06

Net Debt / Equity

-1.47

Sector -33,024.69

Industry -33,024.69

Gross Debt / Equity

0.00

Sector -0.85

Industry -0.85

Equity/Assets

0.60

Sector 0.46

Industry 0.46

Liabilities/Assets

0.40

Sector 0.41

Industry 0.41

Growth

5Y Revenue CAGR

68.08%

Sector -

Industry -

5Y Earnings CAGR

-7.10%

Sector -

Industry -

Fundamentals PRQR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PRQR ProQR Therapeutics N.V.	$1.86	-9.95%	0.00%	-4.81	2.57	-53.39%	-100.00%
JNJ Johnson & Johnson	$269.33	55.44%	1.96%	30.82	7.63	24.76%	21.48%
PFE Pfizer Inc.	$27.49	22.33%	6.26%	35.85	1.83	5.11%	6.86%
ABBV AbbVie Inc.	$263.93	23.34%	2.59%	73.99	-78.76	-106.44%	9.81%
NVO Novo Nordisk A/S	$43.19	-26.70%	4.29%	10.56	5.61	53.11%	35.32%
MRK Merck & Co. Inc.	$146.11	87.14%	2.31%	113.21	8.55	7.55%	4.76%
AZN AstraZeneca PLC	$166.35	9.78%	1.94%	19.88	5.12	25.77%	16.95%
BMY Bristol-Myers Squibb Company	$62.71	43.77%	4.04%	13.67	5.68	41.55%	18.85%
ZTS Zoetis Inc.	$72.66	-49.60%	2.88%	11.47	9.64	84.02%	27.77%
AMGN Amgen Inc.	$383.04	43.28%	2.60%	23.66	17.70	74.80%	22.95%
REGN Regeneron Pharmaceuticals Inc.	$784.44	31.54%	0.47%	18.63	2.54	13.65%	27.86%
HALO Halozyme Therapeutics Inc.	$111.35	46.87%	0.00%	31.57	90.97	288.13%	24.86%
MCK McKesson Corporation	$874.67	27.00%	0.38%	19.57	-26.84	-137.16%	1.29%
VRTX Vertex Pharmaceuticals Incorporated	$506.08	30.72%	0.00%	29.15	6.34	21.76%	35.00%
CAH Cardinal Health Inc.	$224.45	52.89%	0.91%	30.53	-19.32	-63.29%	0.68%
ARGX argenx SE	$994.44	35.42%	0.00%	2.24	2.63	117.11%	44.68%
HRMY Harmony Biosciences Holdings Inc.	$42.23	31.71%	0.00%	13.50	2.45	18.14%	18.88%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PRQR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT ProQR Therapeutics

ProQR Therapeutics N.V.

Average Investor10 user rating

4.0 (0 people)

United States

14 years

Founded: 2012

2014

Time since IPO - 12 years

151

Employees

ProQR Therapeutics N.V. (United States) is listed on the Nasdaq and has a market capitalization of $234.99 million, with shareholders equity totaling $91.56 million.

The company employs approximately 151 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, ProQR Therapeutics N.V. reported $21.31 million in revenue, generating net income of $-48.89 million.

Key financial metrics include a P/E ratio of -4.81, a price-to-book (P/B) ratio of 2.57, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PRQR.

Market cap

$234.99 million

Net worth

$91.56 million

$91,563,000.00

Assets

$153.86 million

$153,863,000.00

Total Shares Outstanding

126.68 million

126,680,000

Average Daily Trading Volume

$818.09 Thousand

$818,094.50

Sector

Health Care

Industry

Biotechnology

PRQR

PRQR revenue and profits

Financial Results PRQR

DRAG THE FRAME TO SEE MORE DATA

PRQR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$874.67 25,76% (12M)

P/E

19.57

0.38%

ROE

-137.16%

P/BV

-26.84

CAH - Cardinal Health

$224.45 51,61% (12M)

P/E

30.53

0.91%

ROE

-63.29%

P/BV

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12M)

P/E

30.82

1.96%

ROE

24.76%

P/BV

7.63

ABBV - AbbVie

$263.93 22,42% (12M)

P/E

73.99

2.59%

ROE

-106.44%

P/BV

-78.76

MRK - Merck & Co.

$146.11 85,19% (12M)

P/E

113.21

2.31%

ROE

7.55%

P/BV

8.55

AZN - AstraZeneca

$166.35 9,17% (12M)

P/E

19.88

1.94%

ROE

25.77%

P/BV

5.12

PFE - Pfizer

$27.49 22,43% (12M)

P/E

35.85

6.26%

ROE

5.11%

P/BV

1.83

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$874.67 25,76% (12 M)

P/L

19.57

0.38%

ROE

-137.16%

P/VP

-26.84

CAH - Cardinal Health

$224.45 51,61% (12 M)

P/L

30.53

0.91%

ROE

-63.29%

P/VP

-19.32

JNJ - Johnson & Johnson

$269.33 56,33% (12 M)

P/L

30.82

1.96%

ROE

24.76%

P/VP

7.63

ABBV - AbbVie

$263.93 22,42% (12 M)

P/L

73.99

2.59%

ROE

-106.44%

P/VP

-78.76

MRK - Merck & Co.

$146.11 85,19% (12 M)

P/L

113.21

2.31%

ROE

7.55%

P/VP

8.55

AZN - AstraZeneca

$166.35 9,17% (12 M)

P/L

19.88

1.94%

ROE

25.77%

P/VP

5.12

PFE - Pfizer

$27.49 22,43% (12 M)

P/L

35.85

6.26%

ROE

5.11%

P/VP

1.83

Frequently Asked Questions

What is the price of ProQR Therapeutics (PRQR) today?

A cotação de ProQR Therapeutics (PRQR) hoje está em US$ 1.86, com uma variação de -11.67% em relação ao último ano. A cotação de ProQR Therapeutics (PRQR) iniciou o ano negociando na casa dos US$ 2.02 e hoje está em US$ 1.86. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de ProQR Therapeutics (PRQR) e dados de ações do Ibovespa e mercados internacionais.

Quando ProQR Therapeutics (PRQR) paga dividendos?

ProQR Therapeutics (PRQR) não distribuiu dividendos no último ano.

Is ProQR Therapeutics (PRQR) a good investment?

Atualmente, ProQR Therapeutics (PRQR) está cotada a US$ 1.86, com um P/L de -4.81, representando um desvio de -584% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de -11.67 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de -11.67%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy ProQR Therapeutics (PRQR) stock?

Investir em ações de ProQR Therapeutics (PRQR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of ProQR Therapeutics (PRQR) yield today?

A rentabilidade de ProQR Therapeutics (PRQR) foi de -20.90% no último mês, -11.67% no último ano e -75.85% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de ProQR Therapeutics (PRQR) hoje, o investimento total seria de US$ 185.50, com base na cotação atual de US$ 1.86.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 163.85
Em 5 anos: US$ 44.80
Em 10 anos: US$ 48.06

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

PRQR

ProQR Therapeutics N.V.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment PRQR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING PRQR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT ProQR Therapeutics

ProQR Therapeutics N.V.

United States

14 years

2014

151

PROFIT X PRICE PRQR

Financial Results PRQR

PRQR cash flow

Asset, Revenue and Profit Growth - PRQR

PRQR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions